|
|
|
| home > white papers > Conveying Medical Guidance in Clinical Trials – A Survey - Europital Medical Consultancy |
|
|
 WHITE PAPERS |
|
Europital Medical Consultancy
|
|
Conveying Medical Guidance in Clinical Trials – A Survey
|
|
With the incremental demand for proactive safety surveillance throughout
the conduct of clinical trials, the role of Medical Management is at
the fore in ensuring the safety and wellbeing of the participants. The
complex responsibilities of a Medical Monitor (MM) starts from the
design and development phase, through to study close out. Understanding
the principle behind the protocol and the prospective medical solution
the study would deliver forms the bloodline for the MM role. Often, the
MM is the face of contact for both the site personnel and the study team
members with regard to medical, safety and scientific issues within the
project.
When it comes to medical guidance, the communication channel used to
deliver solutions contributes to a large extent in effectively managing
decisive situations. Our previous study on acquiring medical guidance
from an operations team perspective revealed that e-mails were the most
used communication method (see the article, 'Talking Points', in ICT November 2014). In our efforts to further strengthen the mode of medical
guidance delivery, we designed a survey to study the existing trend and
constraints in this communication chain management, as outlined here.
|
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
CPhI China opens with analysis pointing to a surge in growth in 2019
Shanghai, 23rd May 2019: New analysis released ahead of CPhI & P-MEC China (#CPhIChina and #PMECChina) – co-organized by Informa Markets, CCCMHPIE, and Shanghai Sinoexpo Informa Markets – forecasts that China will continue to grow strongly through 2019/20, thanks in part to a marked improvement in its global reputation.
More info >> |
|
 |
White Papers |
 |
|
Mouse Models for Evaluation of Vaccines and Therapeutics Against Staphylococcal Infections
IBT Bioservices
Introduction
Staphylococcus aureus (SA) is a ubiquitous, formidable
Gram-positive pathogen associated with skin and soft tissue, as well as
lifethreatening systemic infections. SA is a leading cause of hospital- and
community-associated infections worldwide, affecting humans and animals. The
wide range of pathologies reflects the diverse abilities of this microbe to
escape the innate and adaptive immune response using virulence factors. Since
its first emergence in the 1960s methicillin-resistant SA (MRSA) has become
endemic in hospitals and healthcare settings worldwide. In the 1990s, community
associated MRSA strains (CA-MRSA) emerged, and are spreading worldwide posing a
major global challenge.
More info >> |
|
 |
Industry Events |
 |
CPhI & P-MEC China
18-20 June 2019, SNIEC, Shanghai, China
CPhI & P-MEC China 2019 is your gateway to successfully grow your business at the 2nd largest pharma market in the world. Whether you are looking for sourcing new business or getting the latest market insight, this is your one-stop shop pharmaceutical platform in Asia.
More info >> |
|
|
|
